facebook tracking

Ovarian Cancer Free Patient Webinar Header


Friends of NCCN Foundation Supporter Forum


Please join us for the FIRST Friends of NCCN Foundation Supporter Forum!

This FREE virtual program is designed to be of particular interest to pharmaceutical and biotechnology professionals and patient advocacy group members, but all are welcome to attend.

Hear from expert presenters and learn more about the NCCN Guidelines for Patients® and the Young Investigator Award (YIA) Program.

Two identical sessions will feature the same agenda, so choose the date that works best for you.

Friday, July 24

11:00 AM – 12:30 PM EDT

NCCN Foundation Events

Thursday, July 30

1:00 – 2:30 PM EDT

NCCN Foundation Events

Program features:

  • Interactive presentations from executives and senior staff
  • Focus on the NCCN programs supported by the NCCN Foundation – the NCCN Guidelines for Patients and the Young Investigator Award (YIA) Program
  • Learn how the NCCN Guidelines for Patients are adapted and updated from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
  • Hear how patients and advocacy organizations use the patient guidelines and learn their impact
  • Understand more about the recipients of the Young Investigator Award (YIA) Program and their relevance in cancer research and care

Agenda*:


Welcome

Wendy L. Rees, MBA
Grant Specialist
NCCN Foundation

NCCN & COVID-19

Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

NCCN Foundation Patient Resources Update

Marcie Reeder, MPH
Executive Director
NCCN Foundation

NCCN Guidelines for Patients - Adaptation and Update Process

Dottie Shead, MS
Director, Patient Information Operations
National Comprehensive Cancer Network

Young Investigator Award (YIA) Program Overview

Wui-Jin Koh, MD
Senior Vice President/Chief Medical Officer
National Comprehensive Cancer Network

Closing/Q&A

Gary J. Weyhmuller, MBA, SPHR
Executive Vice President/Chief Operating Officer
National Comprehensive Cancer Network

*Agenda subject to change

Now more than ever before, patients need concrete, trusted, cancer guidance they can understand. Please join us to learn more!